Skip to content
#gene editing Review Open access

GENETIC DISORDERS Molecular Mechanisms, Diagnostic Evolution, Precision Therapeutics and Future Directions: A Narrative Review

Aug 2026 · Zenodo (CERN European Organization for Nuclear Research)
Genomics and Rare Diseases

Abstract

Genetic Disorders: Molecular Mechanisms, Diagnostic Evolution, Precision Therapeutics and Future Directions Description Genetic Disorders: Molecular Mechanisms, Diagnostic Evolution, Precision Therapeutics and Future Directions is a comprehensive narrative review examining the current understanding and rapidly evolving landscape of genetic disorders. The review integrates advances in molecular genetics, genomic diagnostics, precision medicine, and emerging therapeutic strategies to provide a broad perspective on the diagnosis and management of genetic diseases. The review explores the molecular mechanisms underlying genetic disorders, including pathogenic genetic variants, mutations, genomic alterations, gene regulation, and disrupted molecular pathways involved in disease development and progression. It further examines the evolution of genetic diagnosis from conventional approaches toward advanced genomic technologies, including next-generation sequencing (NGS), whole-exome sequencing (WES), whole-genome sequencing (WGS), and molecular diagnostic approaches. A major focus of this review is the development of precision therapeutics and personalized medicine. Emerging approaches such as gene therapy, genome editing, RNA-based therapies, targeted molecular treatments, and genotype-guided therapeutic strategies are discussed in the context of their potential to transform the management of genetic disorders. The review also addresses important challenges in genomic medicine, including variant interpretation, genetic counseling, ethical considerations, accessibility of advanced diagnostic technologies, clinical implementation, and the integration of genomic data into routine healthcare. Finally, the article highlights future directions in genetic medicine, including the potential contributions of artificial intelligence, bioinformatics, multi-omics technologies, genomic data analysis, and precision healthcare. These developments may facilitate earlier diagnosis, improved disease classification, individualized treatment selection, and better clinical outcomes. Overall, this narrative review provides an integrated overview of the transition from traditional genetic diagnosis and management toward genomics-driven, mechanism-based, and precision therapeutic approaches, while identifying key opportunities and challenges for future research and clinical practice. Keywords:Genetic Disorders; Molecular Genetics; Genetic Mutations; Genomic Medicine; Molecular Mechanisms; Genetic Diagnosis; Next-Generation Sequencing; Whole-Exome Sequencing; Whole-Genome Sequencing; Precision Medicine; Precision Therapeutics; Gene Therapy; Genome Editing; RNA-Based Therapy; Personalized Medicine; Bioinformatics; Artificial Intelligence; Genomic Technologies.

View source

Similar papers

#gene editing Review Sep 2026

Unlocking non-model organisms with CRISPR-Cas: A roadmap for sustainable biotechnology.

It is concluded that bridging the gap between foundational CRISPR research and its real-world applications is imperative and future efforts should focus on democratizing tools via open-source platforms, advancing delivery systems, and fostering sustainable innovation through synthetic biology integration to fully realize the transformative potential of genome editing in organisms beyond model organisms.

S. Sarsaiya, Archana Jain, Jishuang Chen et al. · 2 citations
#gene editing Review Open access Aug 2026

Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies

This review summarizes emerging therapeutic strategies for EOC, their mechanisms of action, and their potential to overcome treatment resistance, and covers molecularly targeted therapies, immunotherapies, metabolic and epigenetic approaches, cellular and gene therapies, targeted drug-delivery systems, and locoregional and physical modalities.

Zofia Pietrasik, Mikołaj Kapała, Joanna Pietrasik et al. · 0 citations
#gene editing Review Open access Aug 2026

Environmental Risk Assessment and Confinement of Genetically Engineered Trees with an Emphasis on Vegetative Reproduction.

Genetic engineering (GE) and gene editing may endow traits to trees such as increased biomass and the production of novel biomaterials. Long-lived organisms such as trees might be subject to biotechnology-related risks that could be different than those of annual row crops. Those risks could be relevant to production in engineered plantations and beyond plantations to natural forests. Therefore, appropriate risk regulation is important to assure biosafety of commercialized engineered trees. In addition to gene flow via sexual reproduction, vegetative reproduction might play an additional role in environmental "exposure" risk relative to transgene dispersal in GE tree plantations. While vegetative reproduction is beneficial for preserving desired genetic traits during tree propagation, it may lead to proximal clonal spread in the field. Although the environmental risks associated with vegetative reproduction of GE trees are recognized in commercial forestry, there are few field-based environmental risk assessment (ERA) studies on dispersal risks of self-propagated GE trees. GE or gene editing of target genes involved in the vegetative propagation processes may be useful to mitigate environmental risks of clonal spread through vegetative reproduction. This review provides updates for recent field test results of GE and gene edited trees. Gene candidates related to vegetative reproduction including adventitious shooting (AS) and adventitious rooting (AR) are discussed herein as a means to mitigate unintended clonal spread from GE tree plantations.

Yongil Yang, C. N. Stewart · 0 citations
#gene editing Open access Aug 2026

Programmable RNA targeting with clustered regularly interspaced short palindromic repeats (CRISPR) effector Cas7-11 in zebrafish embryos and mammalian cells

Findings establish Cas7-11 as a precise and efficient RNA knockdown tool for functional studies in embryonic development and stem cell biology, providing a versatile alternative to DNA-based gene-editing approaches.

Huan Yan, Imtiaz Ul Hassan, Kai Yan et al. · 0 citations

Related blog posts

MIT News · Artificial Intelligence Aug 17, 2026

Q&A: Rethinking how innovation happens

In his latest book, Professor Eugene Fitzgerald examines the forces that turn breakthroughs into value — and why innovation resists simple formulas.